NuvOx Therapeutics, Inc. — Form D
NuvOx Therapeutics, Inc. of TUCSON, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-22. The offering totals $7.0M, of which $235K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-11-22
- Form: D
- Accession: 0001213900-24-101639
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $235K
- Remaining: $6.8M
- Minimum investment: $35K
- Investors: 4
- Date of first sale: 2024-09-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-530291
Issuer
- Name: NuvOx Therapeutics, Inc.
- CIK: 0001966126
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1635 E. 18TH STREET, TUCSON, AZ, 85719
- Phone: (520) 624-6688
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Richard T Carmona | Director | Tucson, AZ |
| Jon Saxe | Director | Mountain View, CA |
| Jonathan T Schilling | Director | Tucson, AZ |
| Marvin J Slepian | Director | Tucson, AZ |
| Evan Unger | Director | Tucson, AZ |
| Jennifer Johnson | Executive Officer | NEW YORK, NY |
| Evan Unger | Executive Officer | Tucson, AZ |
| Rong Wang | Executive Officer | Tucson, AZ |
| Jon C Saxe | Director | Tucson, AZ |
| Marvin C Slepian | Director | Tucson, AZ |
| Richard C Carmona | Director | Tucson, AZ |
| Rong C Wang | Executive Officer | Tucson, AZ |
| Evan C Unger | Director | Tucson, AZ |
| Evan C Unger | Executive Officer | Tucson, AZ |
| Jonathan C Schilling | Director | Tucson, AZ |
Other filings by this issuer (1)
More